Biospect
South San Francisco
About Biospect
Biospect, Inc. is developing minimally invasive technology for identifying and assaying protein biomarker patterns that reflect and differentiate biological states. The integrated Biospect system consists of proprietary separations, detection and informatics technologies, and is targeted for use in diagnosing and managing disease or drug development. Biospect is backed by Advent Venture Partners, Prospect Venture Partners, Venrock Associates and Versant Ventures and was incubated by Prospect Venture Partners.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $31.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2003)
- Website: biospect.com
Industries & Categories
Biotechnology, Health Care, Life Science
Canonical: https://fsome.com/organization/biospect-2434571 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.